Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Arq. bras. oftalmol ; 81(6): 490-493, Nov.-Dec. 2018. tab
Article in English | LILACS | ID: biblio-973846

ABSTRACT

ABSTRACT Purpose: To evaluate whether any topical anti-glaucoma medications increase the risk of lacrimal drainage system obstruction or whether the presence of preservatives alone is sufficient to generate obstruction. Methods: This nested case-control study compared a group of patients with lacrimal duct obstruction who received topical anti-glaucoma medications to a control group of patients without obstruction. Results: The medical records of 255 patients with glaucoma who consulted the Oculoplastic Section with complaints of watery eyes were reviewed. Among these patients, 59 exhibited lacrimal drainage obstruction. Ninety-four percent of patients with lacrimal drainage obstruction used beta-blockers, and 41% used prostaglandin analogs. A logistic regression model was used to adjust for age, sex, and the use of other medications. No significant differences were observed regarding the topical anti-glaucoma medications used between groups. Conclusion: No single topical anti-glaucoma medication demonstrated a stronger association with the development of lacrimal duct obstruction.


RESUMO Objetivo: Avaliar se algum medicamento tópico anti-glaucoma aumenta o risco de obstrução do sistema de drenagem lacrimal ou se a presença de conservantes é su fi cien te para gerar obstrução. Métodos: Este estudo de caso-controle aninhado comparou um grupo de pacientes com obstrução do ducto lacrimal que receberam medicações tópicas anti-glaucoma contra um grupo controle de pacientes sem obstrução. Resultados: Foram revistos os prontuários de 255 pacientes com glaucoma que consultaram a Seção de Oculoplástica com queixas de olhos lacrimejantes. Dentre esses pacientes, 59 apresentavam obstrução da via lacrimal de drenagem. Noventa e quatro por cento dos pacientes com obstrução usaram betabloqueadores e 41% usaram análogos de prostaglandinas. Um modelo de regressão logística foi utilizado para ajustar a idade, sexo e o uso de outros medicamentos. Não foram observadas diferenças significativas em relação às medicações tópicas anti-glaucoma usadas entre os grupos. Conclusão: Nenhum medicamento anti-glaucoma tópico único demonstrou uma associação mais forte com o desenvolvimento de obstrução do ducto lacrimal.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Ophthalmic Solutions/therapeutic use , Glaucoma/drug therapy , Lacrimal Duct Obstruction/complications , Preservatives, Pharmaceutical/therapeutic use , Prostaglandins, Synthetic/therapeutic use , Carbonic Anhydrase Inhibitors/therapeutic use , Case-Control Studies , Glaucoma/complications , Retrospective Studies , Adrenergic beta-Antagonists/therapeutic use , Administration, Ophthalmic
3.
Korean Journal of Ophthalmology ; : 216-221, 2012.
Article in English | WPRIM | ID: wpr-171218

ABSTRACT

Chronic sclerosing sialadenitis, also known as Kuttner tumor, is a chronic inflammatory disease of the salivary glands that is reported in a few cases in medical literature. Recent reports suggest that certain aspects of sclerosing diseases, including chronic sclerosing sialadenitis or dacryoadenitis, should be classified under immunoglobulin G4 (IgG4)-related sclerosing disease based on immunohistochemical studies. This study reports an unusual case of IgG4-related sclerosing disease appearing simultaneously in the lacrimal glands, submandibular glands, and extraocular muscles. A 56-year-old male presented with complaints of bilateral eyelid swelling and proptosis that began two years ago. Computed tomography confirmed that bilateral submandibular enlargements also existed five years ago in the subject. Orbital computed tomography and magnetic resonance imaging revealed bilateral lacrimal gland enlargement and thickening of extraocular muscles. Typical findings of chronic sclerosing dacryoadenitis were revealed upon pathologic exam of the right lacrimal gland. Immunostaining revealed numerous IgG4-positive plasma cells. Through these clinical features, we make a diagnosis of IgG4-relataed sclerosing disease in the subject.


Subject(s)
Humans , Male , Middle Aged , Biopsy, Fine-Needle , Diagnosis, Differential , Facial Muscles/immunology , Follow-Up Studies , Immunoglobulin G/immunology , Immunohistochemistry , Lacrimal Apparatus/immunology , Lacrimal Duct Obstruction/complications , Magnetic Resonance Imaging , Sclerosis , Submandibular Gland/immunology , Submandibular Gland Diseases/complications , Tomography, X-Ray Computed
4.
Rev. paul. pediatr ; 21(3): 132-136, set. 2003. ilus, tab
Article in Portuguese | LILACS | ID: lil-349431

ABSTRACT

Objetivo: Caracterizar a obstruçäo de vias lacrimais em crianças portadoras de síndrome de Down. Métodos: Estudo retrospectivo descritivo, envolvendo oito olhos de seis pacientes, com diagnóstico de síndrome de Down, acompanhados no período de 1995 a 2001. Resultados: Todos os pacientes apresentaram quadro de dacriocisite com obstruçao no ducto lacrimonasal. Um paciente apresentava ausência do ponto lacrimal inferior. Três pacientes foram submetidos à dacriocistorrinostomia, três à sondagem e intubaçäo das vias lacrimais. A epífora foi resolvida em três olhos. Conclusöes: No presente estudo, verificou-se que a obstruçäo da via lacrimal ocorreu entre o saco lacrimal e o ducto lacrimonasal, caracterizando o tipo de obstruçäo que ocorre no adulto. O prognóstico foi ruim em 83,3 por cento das intubaçöes e em 66,7 por cento das dacriocistorrinostomias


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Dacryocystorhinostomy , Dacryocystitis , Lacrimal Duct Obstruction/complications , Down Syndrome/complications
5.
SELECTION OF CITATIONS
SEARCH DETAIL